In skeletal muscle, excitation-contraction coupling is the process whereby the voltage-gated dihydropyridine receptor (DHPR) located on the transverse tubules activates calcium release from the sarcoplasmic reticulum by activating ryanodine receptor (RyR1) Ca 2+ channels located on the terminal cisternae. This subcellular membrane specialization is necessary for
Introduction
The precise regulation of intracellular calcium homeostasis is critical for normal skeletal muscle development and function. Excitation-contraction (E-C) coupling requires the correct assembly, distribution and interaction of a number of proteins found in the sarcoplasmic reticulum (SR), the organelle of striated muscle dedicated to calcium homeostasis. Two key elements involved in calcium release are the voltage-gated dihydropyridine receptor (DHPR, MIM# 114208), located on the transverse tubules, and the ryanodine receptor (RyR1, MIM# 180901), the principal calcium release channel of skeletal muscle situated in the terminal cisternae of the SR (Nakai et al., 1996) . The predicted structure of the RyR1 suggests that the calcium release pore is located in the C-terminal domain of the protein, whereas the Nterminal domain constitutes the foot structure that interacts with DHPR (Ramachandran et al., 2009; VanPetegem, 2012; Dulhunty and Pouliquin, 2003) . The direct physical interaction between DHPR and RyR1 is essential for skeletal muscle E-C coupling and any alterations in the subcellular distribution of proteins or membranes involved E-C coupling can lead to impaired muscle function (Pan et al., 2002; Oddoux et al., 2009 ).
Disturbance of calcium homeostasis due to defects in RyR1 is the underlying feature of the malignant hyperthermia susceptibility (MHS, MIM# 145600) trait, a pharmacogenetic reaction to volatile anaesthetics and muscle relaxants, and a wide range of congenital myopathy phenotypes, including dominantly inherited Central Core Disease (CCD, MIM# 117000) and recessively inherited Multi-minicore Disease (MmD, MIM# 255320) with or without opthalmoplegia (Jungbluth et al., 2002; Jungbluth et al., 2005; Quane et al., 1993; Zhou et al., 2006; Zhou et al., 2007) , subgroups of Centronuclear Myopathy (CNM), Congenital Fibre Type Disproportion (CFTD) and the King-Denborough Syndrome (KDS) (Clarke et al., 2010; Dowling et al., 2011; Wilmshurst et al., 2010; Jungbluth et al., 2007) .
Whilst dominantly inherited RYR1-related congenital myopathies have been extensively studied and are usually attributed to RyR1 channels that are either "leaky" or show impaired calcium conductance (Treves et al., 2008; Dirksen and Avila, 2002) , the pathogenesis of recessively inherited RYR1-related myopathies is not well understood, though a decrease in RyR1 protein content has been reported in muscle biopsies from some patients Wilmhurst et al., 2010) . Besides mutations in the RYR1, substitutions in other genes linked to neuromuscular disorders, encoding proteins involved in E-C coupling have so far been reported only for CACNA1, the gene encoding the alfa 1 subunit of the DHPR (Ca v 1.1) in patients with malignant hyperthermia (Pirone et al., 2010; Toppin et al., 2010; Monnier et al., 1997) . We recently reported that a patient with periodic paralysis who harboured recessively inherited RYR1-mutations with no CACNA1S mutation, had a marked reduction of RyR1 protein and a disruption of RyR1/Ca v 1.1 co-localization, indicating potential secondary effects of certain RYR1 mutations on key proteins of the E-C coupling machinery.
In the present investigation we extended these findings and report abnormal expression and distribution of Ca v 1.1 in muscle biopsies from a number of patients with recessive RYR1 mutations with reduced RyR1 content. Mimicking RyR1 depletion in human myotubes using a RYR1 siRNA knock down approach caused a decrease in Ca v 1.1 with a concomitant up-regulation of inositol-1,4,5-trisphosphate receptors (IP3R, MIM# 147265).
These results provide new insights into the pathogenesis of recessive RYR1-related myopathies with primary RyR1 deficiency.
Materials and Methods

Muscle Biopsies
Studies on muscle biopsies from patients were approved by the author's Institutional Ethical Committee and conducted under the Declaration of Helsinki. Patients were encoded to protect their confidentiality, and written informed consent obtained. Routine histopathological studies were performed according to standard procedures. All patients presented in this study have a clear clinical and histological diagnosis of a congenital myopathy, and were molecularly diagnosed as having RYR1 mutations. Control muscle biopsies were from donors with no neuromuscular diseases. RNA samples were studied in 19 patients and 9 controls; immunohistochemical studies were performed in 4 patients and 3 controls; Western blot studies were performed in 2 patients and 3 controls.
Molecular Genetics
The genetic information of all patients was taken from the genetic reports. The RYR1 nucleotide numbering is based on transcript variant NM_00540.2, where the nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence, according to journal guidelines (www.hgvs.org/mutnomen). The initiation codon is codon 1. The variants reported have been submitted to the Leiden RYR1 locus specific database (http://www.lovd.nl/RYR1).
Immortalization and Culture of Skeletal Muscle Cell Line
Human satellite cells were derived from the skeletal muscle biopsy of a 19-year-old female donor with no neuromuscular disorder. Skeletal muscle cell line immortalization was performed as previously described (Zhu et al., 2007; Mamchaoui et al., 2011) . Briefly, cultured cells were double transfected by recombinant retroviruses containing the telomerase (hTERT) cDNA and Cdk4 cDNA, followed by clonal selection of myogenic lines.
Immortalized myoblasts were maintained in skeletal muscle cell growth medium (PromoCell) in low oxygen atmosphere (5% O 2 and 5% CO 2 ) at 37ºC.
Immunofluorescence
All cryosections from muscle biopsies were cut at a thickness of 8 µm for immunohistochemistry. Sections were incubated with primary antibodies at room temperature for one hour, washed in 0.1M phosphate buffered saline pH 7.2 (PBS) and incubated with secondary antibody conjugated to Alexa 488 and biotinylated secondary antibody for one hour at room temperature, followed by thorough rinsing in PBS. After washing, muscle sections were incubated with streptavidin conjugated to Alexa 594 for 15 minutes at room temperature then washed and mounted using Hydromount mounting medium (National Diagnostics). Images were digitally captured using Metamorph software. For immunofluorescence on myotubes, glass coverslip grown cells were fixed for 30 minutes in 3.7% paraformaldehyde in PBS; cells were rinsed with PBS and permeabilized with 1% Triton X-100 in PBS for 30 minutes. After incubation with blocking buffer (1% blocking buffer, Roche, in PBS) for 60 min at room temperature, slides were processed as described above. The primary antibodies used for immunohistochemistry were mouse anti-RyR1 monoclonal antibody (1:500, Abcam), goat anti-Ca v 1.1 polyclonal antibody (1:200, Santa Cruz) and rabbit anti-ß-tubulin (1:20, Santa Cruz).
cDNA Synthesis and Quantitative Real-time PCR
Total RNA was extracted from muscle biopsies using the RNeasy kit (Qiagen); 500 ng of each RNA sample was used for first-strand cDNA synthesis with Superscript III reverse transcription kit (Invitrogen). Quantitative real-time PCR products of RYR1, CACNA1S and DES were amplified with the TaqMan universal PCR Master Mix (Applied Biosystems).
Samples were incubated in a 25µl reaction mix according to manufacturer's instructions.
Quantitative real-time PCR was performed using Applied Biosystem fast 7500 Real Time PCR System using the recommended program: activation at 50ºC for 2 min and 95ºC for 10 min, 40 cycles of 95ºC for 15sec and 60ºC for 1 min. Quantification was based on the comparative ∆∆Ct method. One of the samples treated with negative control siRNA was used to calibrate the data and to analyse results. For ITPR1, ITPR2 and ITPR3 quantitative realtime PCR samples were amplified with MESA Blue qPCR kit (Eurogentec). Gene specific qPCR primers, including ITPR1, ITPR2, ITPR3, GAPDH and DES, were commercially available from Qiagen. Samples were incubated in a 25µl reaction mix according to manufacturer's instructions. Quantitative real-time PCR was performed using Applied Biosystem fast 7500 Real Time PCR System using the recommended program: activation at 95ºC for 5min, 40 cycles of 95ºC for 3sec and 60ºC for 1min. Quantification was based on concurrent standard curves produced from serial dilutions of control cDNA from untreated cultured myotubes. DES and GAPDH were used as internal reference genes. The expression of ITPRs in cultured myotubes or muscle biopsies were normalized by DES or GAPDH, and As well as the ITPR primers described above. Transcript levels were normalized to GAPDH expression levels.
Western Blotting
Total protein was extracted from cells lysates or frozen skeletal muscle sections in sampling buffer consisting of 75 mM Tris-HCl, 1% SDS and cocktail of protease inhibitor (Roche).
Protein concentration was quantified by the BCA protein assay kit (Pierce). Thirty micrograms of proteins were loaded and separated using NuPAGE Pre-cast gels (3-8% Trisacetate, Invitrogen) and then transferred electrophoretically to nitrocellulose membrane (GE Healthcare). The membrane was blocked with 5% goat serum (Sigma) in phosphate buffered saline buffer with 0.5% Tween-20 (PBS-T) and then probed with primary antibodies at room temperature for 1 hour or 4º C overnight. After washing in PBS-T, membranes were incubated with HRP-anti-mouse or HRP-anti-rabbit IgG (the Jackson Laboratory, 1:50,000)
for one hour at room temperature. Immunoreactivity was visualized using enhanced chemiluminescence detection kit (GE Healthcare). Semi-quantification of the bands was performed by densitometric analysis and data was processed using the Image J software.
The primary antibodies used in this study include mouse monoclonal anti-RyR1 (Abcam, 1:2,500), rabbit anti-Ca v 1.1 (Santa Cruz, 1:1,000), mouse monoclonal -anti-desmin (DAKO, 1:2,000), mouse monoclonal anti-IP3R III (BD, 1:1,000), mouse monoclonal anti-SERCA2 antibody (Abcam, 1:1,000), mouse monoclonal anti α-actinin 2 (Sigma, 1:20,000) and mouse monoclonal anti-β-tubulin (Sigma, 1:4,000). and 50nM] of siRNA were tested and cells treated with the same concentrations of negative siRNA were used as control. The transfection medium was changed to differentiation medium (PromoCell) 6 hours post transfection and changed thereafter every 2 days; cells visibly started to fuse 4-5 days after transfection/differentiation, and myotubes were collected at day 7.
Intracellular Calcium Measurements
Myotubes, mock transfected or transfected with 50nM siRNA, were either untreated or treated with 1 µM Xestsospongin C (Sigma chemicals) for 40 minutes during fura-2 (final concentration was 5 µM) loading. Cells were rinsed one time with Krebs-Ringer and then coverslips were mounted onto a 37ºC thermostated chamber which was continuously perfused with Krebs Ringer medium; individual cells were stimulated with the indicated agonists (60 mM KCl, 600 µM 4-chloro-m-cresol, 100 µM ATP) made up in Krebs Ringer containing no added Ca 2+ plus 100 µM La 3+ in order to monitor changes in the cytoplasmic calcium concentration due to release from intracellular stores, by means of a 12-way 100mm diameter quartz micromanifold computer-controlled microperfuser (ALA Scientific Instruments), as previously described (Ducreux et al., 2004) . On-line measurements were recorded using a fluorescent Axiovert S100 TV inverted microscope (Carl Zeiss GmbH, Jena, Germany) equipped with a 20× water-immersion FLUAR objective (0.17 NA), filters (BP 340/380, FT 425, BP 500/530) and attached to a Cascade 125+ CCD camera. Changes in the free cytosolic calcium concentration were analysed using MetaMorph (molecular devices) imaging system and the average pixel value for each cell was measured as previously described (Ducreux et al., 2004; Treves et al., 2010) .
Statistical Analysis
Statistical analysis was performed using the Student's t test for comparison of two samples or the ANOVA test for comparison of multiple data, followed by the Bonferroni's post hoc test.
GraphPad Prism 5 and Origin softwares were used for statistical analysis and graph design.
Results
RyR1 and DHPR Expression and Distribution in Skeletal Muscle Biopsies from Patients
Carrying RYR1 Mutations where histopathology showed typical central or eccentric cores on NADH staining, showed the same patterns of distribution of DHPR and RyR1 in a rim around the core area (Fig. 1 ).
On the other hand, a segregated distribution of RyR1 and DHPR was observed in muscle sections from patients 1 and 2, in whom histopathology showed the characteristic multi-mini cores on NADH staining, there was distinct aggregation of the DHPR in some of the muscle fibres in associated with reduction of RyR1 staining. mRNA was also measured by quantitative real-time but no significant difference was observed in its transcription level in muscle biopsies between mutation groups and controls (Fig. 2B ).
RYR1
We further investigated the effects of RyR1 depletion by performing RyR1 knockdown experiments on an immortalized human muscle cell line, using RYR1 siRNA.
Seven days after transfection and differentiation, once visible multinucleated myotubes appeared, RYR1 mRNA was quantified by real-time PCR. As shown in Fig. 3A the RYR1 transcript was reduced in a siRNA concentration-dependent manner. The relative expression of RYR1 mRNA was: 0.47±0.09 for the 10 nM siRYR1 group; 0.31± 0.03 for the 30 nM siRYR1 group and 0.23±0.03 for the 50 nM siRYR1 group compared to the control group (1.0±0.0). In the same samples the relative expression of CACNA1S (Fig. 3B) and DES ( Fig.   3C) were not significantly changed.
Down-regulation of RyR1 by siRNA did not affect myotube differentiation; indeed mean myotube diameter as well as the relative expression of differentiation-related markers such as dystroglycan 1 (DAG), myosin heavy chain 1 (MHC1), troponin T1 (TNNT1) and desmin (DES) (Galbiati et al., 1999; Trendelenburg et al., 2009) were similar in control and RYR1 siRNA transfected myotubes (Fig. 4) .
RyR1 Deficiency Affects Ca v 1.1 Content
We next assessed if the decrease in mRNA in siRNA transefcted immortalized cells was paralleled by a decrease in protein content. Fig. 5A shows a representative western blot performed seven days after treatment and Fig. 5B shows the mean (±SEM) protein content in control versus siRNA treated myotubes. As shown desmin and tubulin content were not affected by RYR1 siRNA but there was a >50% decrease in RyR1, Ca v 1.1, SERCA2 and α-actinin content as assessed by western blotting in myotubes transfected with 50 nM RYR1 siRNA. Unexpectedly, the relative content of IP3RIII, the other intracellular Ca 2+ release channel of ER membranes was increased by approximately two-fold.
The protein content of Ca v 1.1, SERCA2, α-actinin2 and IP3RIII were also assessed in the muscle biopsies from patients with RyR1 deficiency due to recessive mutations. Western blotting was performed on protein extracted from the muscle biopsies of two patients and three normal controls. The immunohistochemical staining of RyR1 and DHPR of patient 2 was shown in Fig. 1 ; the double staining of RyR1 and DHPR in patient 5 has been previously reported , with similar distribution pattern as shown in Fig. 1 .
Representative blots from patients and controls are shown in Fig. 5C . There was a significant reduction of both RyR1 and DHPR proteins in the samples from the patients compared to controls (N=3) (Fig. 5D ). Significant up-regulation of IP3R III (approximately two-fold) was also observed in patients' muscle biopsies compared to the controls (Fig. 5D ).
However, no changes in SERCA2 and α-actinin 2 protein was observed in the patients' muscle biopsies samples.
All Three Types of ITPRs Transcripts Are Up-regulated in RYR1 Knockdown Myotubes and in Skeletal Muscles from Patients with Primary RyR1 Deficiency
The transcripts of all three isoforms of Inositol-1,4,5-Triphosphate Receptor (IP3R) genes (ITPR1, ITPR2 and ITPR3) were quantified by real-time RT-PCR in myotubes treated by RYR1 siRNA. Significant up-regulation of all three isoforms of ITPRs was observed in the RYR1 knocked down group compared to the control group (Fig. 6A) . We then analysed
ITPRs transcripts in skeletal muscle from controls (N=7), from patients with dominant RYR1 mutations (N=5) and from patients with heterozygous recessive RYR1 mutations and RyR1 protein deficiency (N=6). To ensure that the observed alterations were not due to heterogeneous tissue composition of the biopsies due to variable degrees of fibrosis or connective tissue accumulation, we used both the ubiquitous housekeeping gene GAPDH and muscle specific DES gene as internal reference genes. Irrespective of whether the analysis was made using GAPDH (Fig. 6B) or DES (Fig. 6C) , patients with recessive RYR1 mutations showed significant up-regulations of all three IP3R transcripts, compared to the control group.
No significant differences in ITPR1, ITPR2 and ITP3R expression were observed between the group of patients harbouring dominant RYR1 mutations and the control group, except for a patient carrying the dominant mutation p.R4861C, who showed unusually high levels of ITPRs expression. Interestingly, though this mutation was identified as de novo and was not found in either parent, the case was initially considered a recessive core myopathy because of the severe clinical features of the patient and the abnormality observed in parent's muscle biopsy (Manzur et al., 1998 (Lynch et al., 1999) , or "uncoupled" channels with muscle weakness resulting from a reduced capacity of RyR1 to transport Ca 2 (Avila et al., 2001 ). In the present study, we report that recessive RYR1 mutations associated with RyR1 deficiency are also responsible for E-C uncoupling by negatively affecting DHPR-RyR1 co-localization in skeletal muscle. Indeed, this kind of E-C uncoupling was initially reported in two animal models of RYR1-related disorders, the sporadic zebrafish relatively relaxed mutant with marked reduction of functional RyR1 protein (Hirata et al., 2007) , and in Ryr1 knockout (dyspedic) mice which do not express any ryanodine receptor 1 (Takeshima et al., 1994) . In dyspedic myotubes cultured from Ryr1 knockout mice there is no E-C coupling, whereas introduction of exogenous RyR1 restores E-C coupling and increases the density of the Ltype Ca 2+ current towards normal (Nakai et al., 1996) . The dependence of physiological E-C coupling on correct mechanical coupling is also indicated by ultrastructural studies demonstrating the importance of a tight alignment of RyR tetramers on the junctional face membrane and of DHPR molecules (a tetrad) on the opposing T-tubule membrane (Block et al., 1988) .
Interestingly, depletion of RyR1 in vitro by siRNA in an immortalized human muscle cell line caused a decrease of Ca v 1.1 content, suggesting that proper alignment between the two calcium channels is required for the stability of the complex. Diminishment of Ca v 1.1 content has also been reported in dyspedic mouse skeletal muscle (Buck et al., 1997) and in one previous immunohistochemical study on core myopathies, in which a patient exhibiting virtual absence of RyR1 showed focal accumulation of DHPR within or around the cores (Herasse et al., 2007) . The loss of DHPR/RyR1 co-localization strongly suggests a physical E-C uncoupling in patients with some recessive RYR1 mutations. We suggest that the characteristic staining pattern of Ca v 1.1 may be a useful immunohistochemical indicator to select patients for RYR1 sequencing, currently still very costly and time consuming due to the large size of the gene.
Aside the down-regulation of Ca v 1.1, we observed down-regulation of SERCA2 and alfa-actinin in RyR1 knocked-down myotubes. This is in contrast to the up-regulation of SERCA reported in dyspedic myotubes (Eltit et al., 2010; Eltit et al., 2011) and to the lack of changes in SERCA2 and alfa-actinin protein levels in the patient's biopsies. Opposing effects on SERCA2 expression have been reported in C 2 C 12 cells transfected with two different RYR1 mutations. Vega et al. (Vega et al., 2011) reported that transfection with the RYR1 Y523S MH-linked mutation caused an increase in SERCA2 expression whereas transfection of C2C12 cells with the CCD-linked I4897T RYR1 mutation caused its down-regulation.
Furthermore they also reported that the expression of a particular mutant affects the degree of myotube differentiation, in that C2C12 cells transfected with the RyR1 cDNA harbouring the I4897T mutation were similar to control myotubes in size and fusion index 8 days after differentiation, while cells transfected with the RyR1 cDNA harbouring the Y523S substitution were larger than control myotubes (Vega et al., 2011) . We did not find any significant differences in size and in the expression of differentiation-related markers such as dystroglycan 1, troponin T1, myosin heavy chain and desmin (Galbiati et al., 1999; Trendelenburg et al., 2009) transients and appear to be involved in the regulation of gene expression (Jaimovich et al., 2000; Jaimovich and Carrasco, 2002) . The IP3/IP3R-induced calcium signal plays little or no substantial role in skeletal muscle E-C coupling under physiological conditions (Posterino and Lamb, 1998) and as shown in the present study, up-regulation of IP3R in RyR1-deficient states does not compensate for the physical collapse of the E-C coupling machinery.
Nevertheless, the IP3/IP3R pathway may be involved in slow calcium release leading to activation of expression of certain genes and the present study indicates the possible existence of a complex interplay RyR1 and IP3R signalling pathways. 
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